PharmExec Direct eNewsletter

PharmExec Direct | From the editors of Pharmaceutical Executive

September 24 , 2009 | ISSUE NUMBER 117 VOL 6

R&D
Q&A With Steven Paul: Lilly’s New Development Plan
Lilly’s research lab head Steven Paul talks restructuring plans and the future of the company’s research and development program following last week’s major announcement.

Global
NICE Stats Spur Controversy and Back Patting
The UK’s National Health Service released its first statistics that show how NICE approval has affected medicines uptake in the UK. Pharm Exec has the break down.

Strategy
What Pharma Can Learn From General Manufacturing in a Recession
While pharma is not synchronized with the boom and bust of the general economy, lessons from the business cycle can enable the pharmaceutical industry to tackle the problems it faces, writes Chris Hart of McKinney Rogers.

The Hal Lewis Group promoted Maureen Mangiavas to vice president marketing and strategy, and named Morgan Shinick vice president, account director // Rib-X Pharmaceuticals appointed Tony Zook to its board of directors Caraco Pharmaceutical Laboratories appointed F. Folsom Bell to its board of directors // Ferguson, the founding advertising and promotion agency of CommonHealth, hired Joanna Forbes and Kelly Keating as senior account executives // Merrimack Pharmaceuticals made Clet Niyikiza senior vice president, development // Porzio Pharmaceutical Services hired David E. Hammond as vice president sales and marketing // Micromet appointed Jan Fagerberg, M.D., as senior vice president and chief medical officer //

September 24 Drugs, Devices or Data—Which is Most Valuable? An Expert Panel Debates
Thursday, September 24, 2009 at 2:00 PM EDT

Advertisement:
Meet Pharma’s Best & Brightest in NYC

On Sept 30th, join 250 + top pharma execs, scientists and financiers live at the pharma industry’s version of the Nobel Prize - the Prix Galien Awards.

A great opportunity for high level networking and an authentic feel-good evening.
Finalists include drug agents from Glaxo, Novartis, Wyeth, Amgen, Schering, Pfizer and Sanofi.

Hosted by Charlie Rose and taking place in the magnificent “Whale Room” at NYC’s Museum of Natural History.

Learn More - Pharma's Proudest Night

September 21–24 5th Annual Process Excellence Week for the Service & Transactional World, Chicago, IL

September 30 Prix Galien 2009 Awards Ceremony, New York, NY

October 5–7 BioNetwork 2009: The 7th Annual Pharmaceutical-Biotech Partnering Conference, Laguna Niguel, California

October 20–21 CBI’s Leadership Summit on Global Interactions with Healthcare Providers, Arlington, VA

Is Merck doing a good job integrating Schering-Plough executives into the "New Merck"?

Pipeline Setback for Sanofi and Regeneron

FDA Reviews New OxyContin Formula

US FDA Staff See Potential to Abuse Covidien Drug

Follow Pharm Exec on Twitter

You are subscribed to Pharm Exec Direct.. To unsubscribe, click here

To ensure delivery to your Inbox, please add us to your address book. If you need help doing this, click here.

Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact information available to third parties for marketing purposes, simply call (toll free) 1-866-529-2922 at any time, or fax us at 1-218-740-6417. Outside the U.S., please phone 1-218-740-6395. Contact us by mail at Advanstar Communications Inc., 131 West First St., Duluth, MN 55802-2065, USA.